AI Science Tracker
EN

Integrated analysis of single-cell RNA-seq and spatial transcriptomics to identify the lactylation-related protein TUBB2A as a potential biomarker for glioblastoma in cancer cells by machine learning

Department of Neurosurgery, The Affiliated Hospital of Qingdao University, Qingdao, China · 26 Jun 2025 · medicine

Discovery

Integrated analysis of single-cell RNA-seq and spatial transcriptomics to identify the lactylation-related protein TUBB2A as a potential biomarker for glioblastoma in cancer cells by machine learning

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Machine-learning prioritization linked lactylation scoring to glioblastoma biomarkers; spatial, single-cell and human-tissue assays supported TUBB2A expression differences. The result is limited to the reported study population and evaluation; the source does not establish transfer to other populations or improved clinical outcomes.

Technology: Machine-learning prioritization with lactylation scoring and transcriptomic analyses

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Machine-learning prioritization with lactylation scoring and transcriptomic analyses
Limitation / still unknown
The study does not establish improved patient outcomes or generalization beyond the evaluated setting.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1601533/full · https://doi.org/10.3389/fimmu.2025.1601533 · https://pubmed.ncbi.nlm.nih.gov/40642071/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.